VeriMomchamomilla recutita flower/leaf extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
Pregnancy-safe products containing chamomilla recutita flower/leaf extract
Related ingredients
Frequently asked questions
- chamomilla recutita flower/leaf extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
- chamomilla recutita flower/leaf extract emzirirken güvenli mi?
- Same rationale as pregnancy: no regulatory reproductive classification or CIR/SCCS contraindication for topical cosmetic use. Low but measurable maternal dermal absorption is possible; systemic transfer into milk is not demonstrated for cosmetic topical use. Breastfeeding exposure therefore scored as low (e=1).
- chamomilla recutita flower/leaf extract bebek cildi için güvenli mi?
- No infant-specific safety signals or regulatory reproductive/ developmental classifications. Because infant skin has a higher surface-area-to-weight ratio and a less mature barrier, exposure score is increased by +1 versus adults (adult e=1 → infant e=2), although there are no data showing specific harm to 0–3 year olds from topical chamomile extracts used cosmetically. CIR assessment supports safety as used.
- VeriMom chamomilla recutita flower/leaf extract nasıl puanlıyor?
- VeriMom chamomilla recutita flower/leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte chamomilla recutita flower/leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.